Ambrisentan

FDA Approved: * March 28, 2019
Pharm Company: * WATSON LABS INC
Category: Blood Pressure

Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension.[1][2] The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor (ETA).[3] Ambrisentan significantly improved e... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
4 Discussions

Dosage List

Ambrisentan 5 mg Oral Tablet, Film Coated
NDC: 0378-4270
Labeler:
Mylan Pharmaceuticals Inc.
Ambrisentan 10 mg Oral Tablet, Film Coated
NDC: 0378-4271
Labeler:
Mylan Pharmaceuticals Inc.
Ambrisentan 5 mg Oral Tablet, Film Coated
NDC: 0591-2405
Labeler:
Actavis Pharma, Inc.
Ambrisentan 10 mg Oral Tablet, Film Coated
NDC: 0591-2406
Labeler:
Actavis Pharma, Inc.
Ambrisentan 5 mg Oral Tablet, Film Coated
NDC: 42291-018
Labeler:
Avkare
Ambrisentan 10 mg Oral Tablet, Film Coated
NDC: 42291-019
Labeler:
Avkare
Ambrisentan 5 mg Oral Tablet, Film Coated
NDC: 42794-051
Labeler:
Sigmapharm Laboratories, LLC
Ambrisentan 10 mg Oral Tablet, Film Coated
NDC: 42794-052
Labeler:
Sigmapharm Laboratories, LLC
Ambrisentan 5 mg Oral Tablet, Film Coated
NDC: 47335-236
Labeler:
Sun Pharmaceutical Industries, Inc.
Ambrisentan 10 mg Oral Tablet, Film Coated
NDC: 47335-237
Labeler:
Sun Pharmaceutical Industries, Inc.

Related Brands

Drugs with the same active ingredients

Popular Topics

Is Ambrisentan available in Africa?

Can I find it online? what is the cost? I live in Africa...